# PAPER_Pell_NatureCommunications_2024:

## Intrapartum antibiotic prophylaxis selects for mutators in group B streptococci among persistently colonized patients.
### *Macy E. Pell, Heather M. Blankenship, H. Dele Davies, Shannon D. Manning*
***

### Data Availability
The raw sequencing reads for all genomes examined in this study are available on NCBI under various BioProjects listed below:
* PRJNA1070672, [PRJNA161909](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA161909), [PRJNA86455](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86455), [PRJNA86457](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86457), [PRJNA86459](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86459), [PRJNA86461](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86461), [PRJNA86463](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86463), [PRJNA86465](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86465), [PRJNA86467](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86467), [PRJNA86469](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86469), [PRJNA86471](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86471), [PRJNA86473](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86473), [PRJNA86475](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86475), [PRJNA86477](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86477), [PRJNA86479](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86479), [PRJNA86481](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86481), [PRJNA86483](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86483), [PRJNA86485](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86485), [PRJNA86487](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86487), [PRJNA86489](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86489), [PRJNA86491](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86491), [PRJNA86493](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86493), [PRJNA86495](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86495), [PRJNA86497](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86497), [PRJNA86499](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86499), [PRJNA86501](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86501), [PRJNA86503](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86503), [PRJNA86505](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86505), [PRJNA86507](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86507), [PRJNA86509](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86509), [PRJNA86511](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86511), [PRJNA86513](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86513), [PRJNA86515](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86515), [PRJNA86517](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86517), [PRJNA86519](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86519), [PRJNA86521](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86521), [PRJNA86523](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86523), [PRJNA86525](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86525), [PRJNA86527](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86527), [PRJNA86529](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86529), [PRJNA86531](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86531), and [PRJNA86533](https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA86533)

### Citation

### Abstract
Through vaginal colonization, Group B Streptococcus (GBS) causes severe pregnancy outcomes including neonatal sepsis and meningitis. Although intrapartum antibiotic prophylaxis (IAP) has reduced the incidence of early-onset neonatal disease, persistent GBS colonization has been observed in patients following prophylaxis. To determine whether IAP selects for genomic signatures that enhance GBS survival and persistence in the vaginal tract, whole-genome sequencing was performed on 97 GBS isolates from 58 individuals before (prenatal) and after (postpartum) IAP/childbirth. Core-gene mutation analysis identified 7,025 mutations between the paired prenatal-postpartum isolates; three postpartum isolates accounted for 98% of mutations and were classified as “mutators” because of point mutations within DNA repair systems. Roughly 17% of genes in the mutators were under positive selection, including those encoding surface-associated, attachment, and regulatory proteins. Moreover, in vitro assays revealed stronger biofilm formation in two of the mutators recovered at the postpartum versus prenatal visit. Together, these findings provide evidence of microevolution in GBS recovered from pregnant patients after IAP and suggest that antibiotic treatment selects for mutations that promote survival in vivo. Furthermore, mutators may provide a reservoir of beneficial mutations that enhance fitness, which will simultaneously increase the likelihood of transmission to neonates.


### Acknowledgements and Funding
This work was supported by XX grants. Salary support was prodived by XX. Student support for M.E.P. was provided by the College of Natural Science at Michigan State University (MSU) and the XX and XX awards provided by the Department of Microbiology and Molecular Genetics at MSU. We thank XX at MDHHS for DNA library preparation and sequencing, Jose A. Rodrigues for help with scripts and annotation of pangenome and phylogenetic analyses, Rebekah E. Sloup and Samantha Carbonell for assistance with DNA isolation. 
